Elan's Irish Tax Base Becomes Perrigo's Pot of Gold

REPLAY VIDEO
Your next video will start in
Pause

Recommended Videos

  • Info

  • Comments

July 29 (Bloomberg) -- Bloomberg's Olivia Sterns reports on the $8.6 billion by Perrigo Co. to purchase Irish drug company Elan Corp. and the tax relief Ireland's tax-base may bring to the drugmaker, plus a look at what may be a split of internal operations by Pfizer. She speaks on Bloomberg Television's "Market Makers."

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change